Anal CancerThis is an RSS file. You can use it to subscribe to this data in your favourite RSS reader, such as GoogleReader, or to display this data on your own website or blog. Subscribe to this data using MyMedWorm.Subscribe to this data using GoogleReader.Subscribe to this data using Bloglines.Subscribe to this data using MyYahoo.

This page shows you your search results in order of date.

Pages: 1 2 3 4 5

210 records returned

Randomized Clinical Trials in Rectal and Anal CancersEmail this article to a colleague. Save this article to My Clippings. Discuss or comment on this article.
This article reviews randomized clinical trials (RCTs) published between April 2001 and November 2008 on the management of patients with rectal cancer. In total, the authors reviewed 78 RCTs on therapy for rectal cancer. Of these, five met the authors' criteria for level 1a evidence. The article discusses the major RCTs and relevant findings that have impacted clinical management most and includes most but not all RCTs on therapy for rectal cancer published during this period. (Source: Surgical Oncology Clinics of North America)
Source: Surgical Oncology Clinics of North America - November 16, 2009 Category: Surgery Authors: Jason Park, Heather B. Neuman, Martin R. Weiser, W. Douglas Wong Source Type: journals

Health Advice: How Common Is Anal Cancer?Email this article to a colleague. Save this article to My Clippings. Discuss or comment on this article.
Farrah Fawcett's death earlier this year made reader wonder: What's my risk? (Source: U.S. News - Health)
Source: U.S. News - Health - November 10, 2009 Category: Consumer Health News Source Type: consumer

A treatment planning study comparing helical tomotherapy with intensity-modulated radiotherapy for the treatment of anal cancer.Email this article to a colleague. Save this article to My Clippings. Discuss or comment on this article.
CONCLUSIONS: HT and IMRT techniques achieved comparable target dose coverage and organ sparing, whereas HT plans were more homogeneous for both men and women. PMID: 19896229 [PubMed - as supplied by publisher] (Source: Radiotherapy and Oncology : journal of the European Society for Therapeutic Radiology and Oncology)
Source: Radiotherapy and Oncology : journal of the European Society for Therapeutic Radiology and Oncology - November 4, 2009 Category: Radiology Authors: Joseph KJ, Syme A, Small C, Warkentin H, Quon H, Ghosh S, Field C, Pervez N, Tankel K, Patel S, Usmani N, Severin D, Nijjar T, Fallone G, Pedersen J Tags: Radiother Oncol Source Type: journals

A fast radiotherapy paradigm for anal cancer with volumetric modulated arc therapy (VMAT)Email this article to a colleague. Save this article to My Clippings. Discuss or comment on this article.
Conclusion: VMAT provides treatment plans with high conformity and homogeneity equivalent to step-and-shoot-IMRT for this mono-concave treatment volume. Short treatment delivery time and low primary MU are the most important advantages. (Source: Radiation Oncology)
Source: Radiation Oncology - October 25, 2009 Category: Cancer & Oncology Authors: Florian StielerDirk WolffFrank LohrVolker SteilYasser Abo-MadyanFriedlieb LorenzFrederik WenzSabine Mai Source Type: journals

The Same Virus That Causes Cervical Cancer is the Culprit of Anal Cancer TooEmail this article to a colleague. Save this article to My Clippings. Discuss or comment on this article.
Anal cancer has been put in the spotlight with Farrah Fawcetts's battle with the disease. What many people are starting to learn is that a common virus, HPV, is a major risk risk factor for developing anal cancer. HPV is a virus transmitted thorugh sexual contact and it is estimated that over 20 million Americans are infected. There are over 100 different types of HPV, however only a few are responsible for cancer development. HPV is also the leading cause of cervical cancer, a disease that plagues of 9,000 American women each year. The good news is that most cases of HPV clear up on their own before progressing to cancer....
Source: About.com Cervical Cancer - October 19, 2009 Category: Cancer & Oncology Source Type: consumer

FDA Panel Approves HPV Vaccine for BoysEmail this article to a colleague. Save this article to My Clippings. Discuss or comment on this article.
The Food and Drug Administration (FDA) has given its approval for boys age 9 to 26 to receive the HPV vaccine Gardasil. The vaccine has been in use with females 9 to 26 since 2006. HPV, also known as human papillomavirus can cause cervical cancer in women. In men HPV can lead to anal cancers and genital warts. While there are dozens of strains of HPV, Gardasil targets the 4 that most commonly cause cancers and rectal warts. Ideally, the vaccine is gotten before becoming sexually active since that is the way HPV is transmitted. Note that for now, Gardasil use in boys is only being considered in the prevention of rectal wart...
Source: About AIDS / HIV - October 17, 2009 Category: Consumer Health Advice Source Type: consumer

Treatment and survival outcomes for anal cancer: A ten year retrospective review in one hospitalEmail this article to a colleague. Save this article to My Clippings. Discuss or comment on this article.
Introduction: Anal cancer is rare. We have conducted a retrospective review to determine the extent of our adherence to national guidelines and survival after treatment of anal cancer at our hospital. (Source: European Journal of Surgical Oncology)
Source: European Journal of Surgical Oncology - October 16, 2009 Category: Cancer & Oncology Authors: Jeffrey Lim, J. Fallon, G. Waters, B. Lieske, J. Gildersleve, R. Robertson, R. Farouk Tags: Abstracts Source Type: journals

Exercise reduces fatigue in chemo patientsEmail this article to a colleague. Save this article to My Clippings. Discuss or comment on this article.
Study shows significantly less fatigue in exercise groupRelated items from OnMedicaCancer survival rates not improved much in a decade Free prescriptions for cancer patients Scientists make cancer break through Cancer survivors more prone to stress than othersCombined treatment works best for anal cancer (Source: OnMedica Latest News)
Source: OnMedica Latest News - October 13, 2009 Category: UK Health Source Type: news

Anal cancer; do we all have a common treatment strategy?Email this article to a colleague. Save this article to My Clippings. Discuss or comment on this article.
(Source: Colorectal Disease)
Source: Colorectal Disease - October 13, 2009 Category: Gastroenterology Authors: Najib Haboubi Tags: Editorial Source Type: journals

Commentary: Anal cancer – the benefits of evidence-based treatmentEmail this article to a colleague. Save this article to My Clippings. Discuss or comment on this article.
(Source: Colorectal Disease)
Source: Colorectal Disease - October 11, 2009 Category: Gastroenterology Authors: James Hill Tags: Original Articles Source Type: journals

Immune-Suppressed HIV Patients are at Risk of Seven Types of CancerEmail this article to a colleague. Save this article to My Clippings. Discuss or comment on this article.
“The weakened immune systems of people with HIV [put] them at increased risk for at least seven types of cancer, but early diagnosis and treatment of HIV infection could help delay the onset of some of these cancers, a new study suggests.“French researchers examined the incidence of three AIDS-defining cancers (Kaposi's sarcoma, non-Hodgkin's lymphoma and cervical cancer) and four non-AIDS-defining cancers (Hodgkin's lymphoma, lung cancer, liver cancer and anal cancer) in 52,278 HIV-infected people….“Overall, immunodeficiency increased the risk of all the cancers, and CD4 cell count was the most predictive risk fac...
Source: AIDSinfo At-a-Glance: Offering Information on HIV/AIDS Treatment, Prevention, and Research, A Service of the U.S. Department of Health and Human Services (DHHS) - October 8, 2009 Category: Infectious Diseases Source Type: info

Lack of correlation between p53 codon 72 polymorphism and anal cancer risk.Email this article to a colleague. Save this article to My Clippings. Discuss or comment on this article.
CONCLUSION: These results do not support a role for the p53 codon 72 polymorphism in anal carcinogenesis. PMID: 19777616 [PubMed - in process] (Source: World Journal of Gastroenterology : WJG)
Source: World Journal of Gastroenterology : WJG - September 26, 2009 Category: Gastroenterology Authors: Contu SS, Agnes G, Damin AP, Contu PC, Rosito MA, Alexandre CO, Damin DC Tags: World J Gastroenterol Source Type: journals

Squamous cell cancer of the rectum.Email this article to a colleague. Save this article to My Clippings. Discuss or comment on this article.
Squamous cell carcinoma of the rectum is a rare malignancy. It appears to be associated with chronic inflammatory conditions and infections. The clear association seen between Human Papilloma Virus and various squamous cancers has not been firmly established for the squamous cell cancer of the rectum. The presentation is nonspecific and patients tend to present with advanced stage disease. Diagnosis relies on endoscopic examination with biopsy of the lesion. Distinction from squamous cell cancer of the anus can be difficult, but can be facilitated by immunohistochemical staining for cytokeratins. Staging of the cancer ...
Source: World Journal of Gastroenterology : WJG - September 20, 2009 Category: Gastroenterology Authors: Dyson T, Draganov PV Tags: World J Gastroenterol Source Type: journals

PJ O'Rourke: a hellraiser who had to slow downEmail this article to a colleague. Save this article to My Clippings. Discuss or comment on this article.
PJ O'Rourke America's favourite living wit talks to Philip Sherwell about drugs cars and his recent brush with cancer (Source: Telegraph Health)
Source: Telegraph Health - September 19, 2009 Category: Consumer Health News Tags: pj o'rourke p j orourke ororke gonzo obama anal cancer cars General Motors Source Type: news

Pap smears for men: a vision of the future?Email this article to a colleague. Save this article to My Clippings. Discuss or comment on this article.
Conclusions The paper concludes by briefly discussing the implications of a national screening programme against AIN in the future. Content Type Journal ArticleCategory Case ReportDOI 10.1007/s11845-009-0340-6Authors S. F. Oon, St. Vincent’s University Hospital Department of Colorectal Surgery Elm Park Dublin 4 IrelandA. Hanly, St. Vincent’s University Hospital Department of Colorectal Surgery Elm Park Dublin 4 IrelandD. C. Winter, St. Vincent’s University Hospital Department of Colorectal Surgery Elm Park Dublin 4 Ireland Journal Irish Journal of Medical ScienceOnline ISSN 1863-4362Print ...
Source: Irish Journal of Medical Science - September 17, 2009 Category: Journals (General) Tags: Irish Journal of Medical Science Source Type: journals

Anal cancer: One step forward – Two steps sideways!Email this article to a colleague. Save this article to My Clippings. Discuss or comment on this article.
Someone, or nobody, knows I wotWho or which or why or whatIs the Akond of Swat! The final verse of Edward Lear’s non-sense poem ‘The Akond of Swat’ could well describe our increasingly slippery grasp on how to improve the current treatment of anal cancer, which continues to elude us. Several recent trials have tantalisingly provided negative results – although overall results appear to be improving. (Source: European Journal of Cancer)
Source: European Journal of Cancer - September 16, 2009 Category: Cancer & Oncology Authors: R. Glynne-Jones Tags: Editorial comment Source Type: journals

The truth about chemotherapy and the cancer industry (comic)Email this article to a colleague. Save this article to My Clippings. Discuss or comment on this article.
(NaturalNews) Patrick Swayze's death came as a shock to many people. But not to his own cancer doctor: They know that the five-year survival rates of people being treated with chemotherapy for pancreatic cancer are virtually zero. And Swayze was only the latest in a long list of celebrities dying after being treated with chemotherapy and other toxic forms of western medicine:Farrah Fawcett died following chemotherapy used to treat anal cancer and liver cancer. (http://www.naturalnews.com/026511_cancer_chemotherapy_doctors.html)Famed newscaster Peter Jennings died from chemotherapy treatments for lung cancer.Former White Ho...
Source: NaturalNews.com - September 16, 2009 Category: Consumer Health Advice Source Type: news

A multi-institutional acute gastrointestinal toxicity analysis of anal cancer patients treated with concurrent intensity-modulated radiation therapy (IMRT) and chemotherapyEmail this article to a colleague. Save this article to My Clippings. Discuss or comment on this article.
Abstract: Using previous dosimetric analysis methods, we identified the volume of bowel receiving 30Gy (V30) correlated with acute gastrointestinal (GI) toxicity in anal cancer patients treated with intensity-modulated radiation therapy and concurrent chemotherapy. For V30>450cc and⩽450cc, acute GI toxicity was 33% and 8%, respectively (p=0.003). (Source: Radiotherapy and Oncology)
Source: Radiotherapy and Oncology - September 1, 2009 Category: Radiology Authors: Kiran Devisetty, Loren K. Mell, Joseph K. Salama, David A. Schomas, Robert. C. Miller, Ashesh B. Jani, John C. Roeske, Bulent Aydogan, Steven J. Chmura Tags: Original articles Source Type: journals

A multi-institutional acute gastrointestinal toxicity analysis of anal cancer patients treated with concurrent intensity-modulated radiation therapy (IMRT) and chemotherapy.Email this article to a colleague. Save this article to My Clippings. Discuss or comment on this article.
Using previous dosimetric analysis methods, we identified the volume of bowel receiving 30Gy (V(30)) correlated with acute gastrointestinal (GI) toxicity in anal cancer patients treated with intensity-modulated radiation therapy and concurrent chemotherapy. For V(30)>450cc and450cc, acute GI toxicity was 33% and 8%, respectively (p=0.003). PMID: 19717198 [PubMed - as supplied by publisher] (Source: Radiotherapy and Oncology : journal of the European Society for Therapeutic Radiology and Oncology)
Source: Radiotherapy and Oncology : journal of the European Society for Therapeutic Radiology and Oncology - August 27, 2009 Category: Radiology Authors: Devisetty K, Mell LK, Salama JK, Schomas DA, Miller RC, Jani AB, Roeske JC, Aydogan B, Chmura SJ Tags: Radiother Oncol Source Type: journals

Growth factor receptor expression in anal squamous lesions: modifications associated with oncogenic human papillomavirus and human immunodeficiency virusEmail this article to a colleague. Save this article to My Clippings. Discuss or comment on this article.
Summary: High prevalence of squamous anal lesions is linked to oncogenic human papillomavirus (HPV). Human immunodeficiency virus (HIV) promotes anal carcinogenesis. Epidermal growth factor receptor (EGFR), HER2/neu, c-Met, and vascular endothelial growth factor receptor-1 (VEGFR1) (tyrosine kinase growth factor receptors) are implicated in tumor progression, but little is known about their role in anal lesions. We investigated their expression and distribution in normal, dysplastic, and carcinomatous anal epithelium and then tried to analyze the effects on these variables of HPV and the HIV-positive status. Seventy-one HI...
Source: Human Pathology - August 27, 2009 Category: Pathology Authors: Francine Walker, Laurent Abramowitz, Dalila Benabderrahmane, Xavier Duval, Véronique Descatoire, Dominique Hénin, Thérèse Lehy, Thomas Aparicio Tags: Original Contributions Source Type: journals

Risk of Human Papillomavirus-Associated Cancers Among Persons With AIDSEmail this article to a colleague. Save this article to My Clippings. Discuss or comment on this article.
Conclusions Risk of HPV-associated cancers was elevated among persons with AIDS and increased with increasing immunosuppression. The increasing incidence for anal cancer during 1996–2004 indicates that prolonged survival may be associated with increased risk of certain HPV-associated cancers. (Source: JNCI)
Source: JNCI - August 17, 2009 Category: Cancer & Oncology Authors: Chaturvedi, A. K., Madeleine, M. M., Biggar, R. J., Engels, E. A. Tags: ARTICLES Source Type: journals

Anal cancer treated with radio-chemotherapy: correlation between length of treatment interruption and outcomeEmail this article to a colleague. Save this article to My Clippings. Discuss or comment on this article.
Conclusions Definitive radio-chemotherapy with short individualised treatment interruption shows high local control and colostomy-free survival rates. Content Type Journal ArticleCategory Original ArticleDOI 10.1007/s00384-009-0775-2Authors Stefan Janssen, Medical School Hannover Department of Radiation Oncology Carl-Neuberg-Str. 1 30625 Hannover GermanyJürgen Meier zu Eissen, Sophienklinik Hannover Department of Coloproctology Hannover GermanyGerd Kolbert, Sophienklinik Hannover Department of Coloproctology Hannover GermanyMichael Bremer, Medical School Hannover Department of Radiation Oncology Carl-...
Source: International Journal of Colorectal Disease - July 31, 2009 Category: Gastroenterology Tags: International Journal of Colorectal Disease Source Type: journals

Mitomycin C with continuous fluorouracil or with cisplatin in combination with radiotherapy for locally advanced anal cancer (European Organisation for Research and Treatment of Cancer phase II study 22011-40014)Email this article to a colleague. Save this article to My Clippings. Discuss or comment on this article.
Abstract: Purpose: To assess the feasibility and activity of radio-chemotherapy with mitomycin C (MMC) and cisplatin (CDDP) in locally advanced squamous cell anal carcinoma with reference to radiotherapy (RT) combined with MMC and fluorouracil (5-FU).Patients and methods: Patients with measurable disease >4cmN0 or N+ received RT (36Gy+2week gap+23.4Gy) with either MMC/CDDP or MMC/5-FU (MMC 10mg/m2 d1 of each sequence; 5-FU 200mg/m2/day c.i.v. daily; CDDP 25mg/m2 weekly). Forty patients/arm were needed to exclude a RECIST objective response rate (ORR), 8weeks after treatment, of 75%) to be tested further in phase III trials...
Source: European Journal of Cancer - July 29, 2009 Category: Cancer & Oncology Authors: O. Matzinger, F. Roelofsen, L. Mineur, S. Koswig, E.M. Van Der Steen-Banasik, P. Van Houtte, K. Haustermans, L. Radosevic-Jelic, R.P. Mueller, P. Maingon, L. Collette, J.F. Bosset, for the EORTC Radiation Oncology and Gastrointestinal Tract Cancer Groups Tags: Clinical oncology Source Type: journals

Anal Pap smears: Should we be doing them?Email this article to a colleague. Save this article to My Clippings. Discuss or comment on this article.
Conclusions: Performing anal Pap smears is a valuable tool to detect cytologic changes associated with some strains of HPV infection. For persons participating in receptive anal intercourse, this diagnostic procedure provides the opportunity for early detection to guide appropriate follow-up and interventions.Implications for practice: Appropriate screening can be incorporated easily into a primary care practice. High-risk groups that would benefit from this screening include men who have sex with men, HIV-infected men and women, immunocompromised men and women, women with a history of cervical or vulvar cancer (or high-gr...
Source: Journal of the American Academy of Nurse Practitioners - July 27, 2009 Category: Nursing Authors: Kimberley Lindsey, Claire DeCristofaro, Janet James Tags: PRACTICE Source Type: journals

Squamous cell carcinoma of the anus in a patient with perianal Crohn’s diseaseEmail this article to a colleague. Save this article to My Clippings. Discuss or comment on this article.
Content Type Journal ArticleCategory Letter to the EditorDOI 10.1007/s00384-009-0778-zAuthors Jeonghyun Kang, Yonsei University Health System, Yonsei University College of Medicine Department of Surgery 250 Seongsanno (134 Sinchon-dong), Seodaemun-gu Seoul South Korea 120-752Byung Soh Min, Yonsei University Health System, Yonsei University College of Medicine Department of Surgery 250 Seongsanno (134 Sinchon-dong), Seodaemun-gu Seoul South Korea 120-752Kang Young Lee, Yonsei University Health System, Yonsei University College of Medicine Department of Surgery 250 Seongsanno (134 Sinchon-dong), Seodaemun-gu Seoul South ...
Source: International Journal of Colorectal Disease - July 27, 2009 Category: Gastroenterology Tags: International Journal of Colorectal Disease Source Type: journals

Anal Cancer Isn't Being Caught Early: Doctors Lament Victims' Reluctance To Seek CheckupsEmail this article to a colleague. Save this article to My Clippings. Discuss or comment on this article.
If caught in time, anal cancer isn't typically deadly and doesn't require surgery. But a lack of awareness and a general reluctance to pay attention to symptoms in the anal area are fueling mortality rates, medical experts say. "Unfortunately, when we catch it, it is usually too late," said Dr. Vassiliki L. Tsikitis, a colorectal surgeon at the Arizona Cancer Center in Tucson. "We are doing better in catching other cancers, but with anal cancer, it's not being caught." Though uncommon, anal cancer is also on the rise in the United States -- increasing at a rate of 2.1 percent per year since 1975, the National Cancer Instit...
Source: Cancercompass News: Other Cancer - July 15, 2009 Category: Cancer & Oncology Source Type: news

Feasibility of integrated CT-liver perfusion in routine FDG-PET/CTEmail this article to a colleague. Save this article to My Clippings. Discuss or comment on this article.
Conclusion Combined CT-perfusion/PET/CT-protocol without the use of additional contrast media is feasible and can be easily integrated in clinical routine. Perfusion parameters and PET-parameters are only partly correlating and therefore have to be investigated further at fixed time points during the course of disease and therapy. Content Type Journal ArticleDOI 10.1007/s00261-009-9559-yAuthors Patrick Veit-Haibach, University Hospital Zuerich Department of Medical Radiology, Division of Nuclear Medicine Raemistrasse 100 8091 Zuerich SwitzerlandValerie Treyer, University Hospital Zuerich Department of...
Source: Abdominal Imaging - July 11, 2009 Category: Radiology Tags: Abdominal Imaging Source Type: journals

Anal cancerEmail this article to a colleague. Save this article to My Clippings. Discuss or comment on this article.
Last updated 27 March 2009This section of CancerHelp UK tells you about cancer of the anus. It includes symptoms and causes, tests and treatment, living with anal cancer, and current research. (Source: Gastroenterology and Liver Diseases Specialist Library - Colon and rectum)
Source: Gastroenterology and Liver Diseases Specialist Library - Colon and rectum - July 7, 2009 Category: Gastroenterology Source Type: organizations

What Is Anal Cancer? What Causes Anal Cancer?Email this article to a colleague. Save this article to My Clippings. Discuss or comment on this article.
Anal cancer occurs in the anus, the end of the gastrointestinal tract. Anal cancer is very different from colorectal cancer, which is much more common. Anal cancer's causes, risk factors, clinical progression, staging and treatment are all very different from colorectal cancer. Anal cancer is a lump which is created by the abnormal and uncontrolled growth of cells in the anus. (Source: Health News from Medical News Today)
Source: Health News from Medical News Today - July 7, 2009 Category: Consumer Health News Tags: Colorectal Cancer Source Type: news

Cost-utility analysis of screening high-risk groups for anal cancerEmail this article to a colleague. Save this article to My Clippings. Discuss or comment on this article.
A structured abstract written by CRD reviewers. The abstract was published on 24 June 2009 from an original article published in 2008. (Source: Gastroenterology and Liver Diseases Specialist Library - Prevention)
Source: Gastroenterology and Liver Diseases Specialist Library - Prevention - July 6, 2009 Category: Gastroenterology Source Type: organizations

Fawcett's legacy beyond the biz: Spotlighting rare cancerEmail this article to a colleague. Save this article to My Clippings. Discuss or comment on this article.
In a perverse twist of medical fate, Farrah Fawcett has become the poster girl for anal cancer, a rare disease often linked to ... (Source: USATODAY.com Health)
Source: USATODAY.com Health - July 2, 2009 Category: Consumer Health News Source Type: news

Fawcett's death spotlights a rare cancerEmail this article to a colleague. Save this article to My Clippings. Discuss or comment on this article.
In a perverse twist of medical fate, Farrah Fawcett has become the poster girl for anal cancer, a rare disease often linked to a sexually transmitted virus. (Source: CTV Health)
Source: CTV Health - July 2, 2009 Category: Consumer Health News Source Type: news

Fawcett's Anal Cancer: Fighting the StigmaEmail this article to a colleague. Save this article to My Clippings. Discuss or comment on this article.
Farrah Fawcett's death highlights the unspoken assumptions about the disease. (Source: ABC News: Health)
Source: ABC News: Health - June 27, 2009 Category: Consumer Health News Source Type: news

Michael Jackson, Farrah Fawcett the Latest Celebrity Victims of Big PharmaEmail this article to a colleague. Save this article to My Clippings. Discuss or comment on this article.
(NaturalNews) That Michael Jackson and Farrah Fawcett both died in the last 48 hours is shocking news to many, but it's not nearly as surprising as the fact that they were both killed by Big Pharma's toxic drugs.Michael Jackson, we now know, died from an injection of Demerol given by his doctor -- a man who is now the subject of an LAPD manhunt. There is little question that the injection of Demerol -- a potent pharmaceutical -- caused Jackson's death. Chalk it up to yet another tragic loss of a hugely inspiring artist who has become a victim of the pharmaceutical industry and overzealous medical doctors.Demerol, by the wa...
Source: NaturalNews.com - June 26, 2009 Category: Consumer Health Advice Source Type: news

Farrah Fawcett Dies of Anal CancerEmail this article to a colleague. Save this article to My Clippings. Discuss or comment on this article.
Fawcett, 62, was diagnosed with anal cancer in 2006. WebMD Health News (Source: Medscape Today Headlines)
Source: Medscape Today Headlines - June 25, 2009 Category: Consumer Health News Tags: Hematology-Oncology Source Type: news

Farrah Fawcett Dies at Age 62Email this article to a colleague. Save this article to My Clippings. Discuss or comment on this article.
Hollywood legend Farrah Fawcett has passed away, succumbing to her long battle with anal cancer. She died Thursday morning, according to her publicist. Farrah was diagnosed with anal cancer in... (Source: About.com Cancer)
Source: About.com Cancer - June 25, 2009 Category: Cancer & Oncology Source Type: consumer

Farrah Fawcett Dies of Anal CancerEmail this article to a colleague. Save this article to My Clippings. Discuss or comment on this article.
Title: Farrah Fawcett Dies of Anal CancerCategory: Health NewsCreated: 6/25/2009Last Editorial Review: 6/25/2009 (Source: MedicineNet Cancer General)
Source: MedicineNet Cancer General - June 25, 2009 Category: Cancer & Oncology Source Type: consumer

Farrah Fawcett Dies of Anal CancerEmail this article to a colleague. Save this article to My Clippings. Discuss or comment on this article.
(Source: eMedicineHealth.com)
Source: eMedicineHealth.com - June 25, 2009 Category: Journals (General) Source Type: info

Farrah Fawcett Dies of Anal CancerEmail this article to a colleague. Save this article to My Clippings. Discuss or comment on this article.
Title: Farrah Fawcett Dies of Anal CancerCategory: Health NewsCreated: 6/25/2009Last Editorial Review: 6/25/2009 (Source: MedicineNet Digestion General)
Source: MedicineNet Digestion General - June 25, 2009 Category: Nutrition Source Type: consumer

Farrah Fawcett Dies of Anal CancerEmail this article to a colleague. Save this article to My Clippings. Discuss or comment on this article.
Title: Farrah Fawcett Dies of Anal CancerCategory: Health NewsCreated: 6/25/2009Last Editorial Review: 6/25/2009 (Source: MedicineNet Womens Health General)
Source: MedicineNet Womens Health General - June 25, 2009 Category: OBGYN Source Type: consumer

Farrah Fawcett Dies of Anal CancerEmail this article to a colleague. Save this article to My Clippings. Discuss or comment on this article.
Former "Charlie's Angel" Farrah Fawcett has died after a long struggle with anal cancer. (Source: WebMD Health)
Source: WebMD Health - June 25, 2009 Category: Consumer Health News Source Type: news

Chemoradiation Protocol for Anal Cancer Doesn't Need Fixing, UK Investigators SayEmail this article to a colleague. Save this article to My Clippings. Discuss or comment on this article.
ORLANDO (EGMN) - Stay the course in the treatment of squamous cell carcinoma of the anus, U.K. investigators recommended based on trial results presented at the annual meeting of the American Society of... (Source: OncologySTAT Latest News)
Source: OncologySTAT Latest News - June 11, 2009 Category: Cancer & Oncology Source Type: news

Treatment of Anal CancerEmail this article to a colleague. Save this article to My Clippings. Discuss or comment on this article.
Title: Treatment of Anal CancerCategory: Doctor's ViewsCreated: 6/2/2009Last Editorial Review: 6/5/2009 (Source: MedicineNet Cancer General)
Source: MedicineNet Cancer General - June 5, 2009 Category: Cancer & Oncology Source Type: consumer

Treatment of Anal CancerEmail this article to a colleague. Save this article to My Clippings. Discuss or comment on this article.
Title: Treatment of Anal CancerCategory: Doctor's ViewsCreated: 6/2/2009Last Editorial Review: 6/5/2009 (Source: MedicineNet Womens Health General)
Source: MedicineNet Womens Health General - June 5, 2009 Category: OBGYN Source Type: consumer

ASCO: Anal CA Standard Care Beats Challenger (CME/CE)Email this article to a colleague. Save this article to My Clippings. Discuss or comment on this article.
ORLANDO (MedPage Today) -- The current standard of care for anal cancer prevailed over a new strategy in a large randomized clinical trial. (Source: MedPage Today Hematology/Oncology)
Source: MedPage Today Hematology/Oncology - June 4, 2009 Category: Hematology Source Type: news

ASCO 2009: Standard of Care for Anal Cancer Should Not Be ChangedEmail this article to a colleague. Save this article to My Clippings. Discuss or comment on this article.
Results from the largest trial to date conducted for anal cancer shows that the current standard of care (chemoradiotherapy with 5-fluorouracil and mitomycin-C) results in the best outcomes, Medscape Medical News (Source: Medscape Today Headlines)
Source: Medscape Today Headlines - May 31, 2009 Category: Consumer Health News Tags: Hematology-Oncology Source Type: news

Clinical Trials in the Management of Anal CancerEmail this article to a colleague. Save this article to My Clippings. Discuss or comment on this article.
This article aims to provide a summary of recently completed and ongoing clinical trials in the management of anal canal cancer.[...]© Thieme Medical PublishersGet connected:Table of contents | Abstract | Full text (Source: Clinics in Colon and Rectal Surgery)
Source: Clinics in Colon and Rectal Surgery - May 28, 2009 Category: Surgery Source Type: journals

Anal Cancer and Retrorectal TumorsEmail this article to a colleague. Save this article to My Clippings. Discuss or comment on this article.
Clinics in Colon and Rectal Surgery 2009; 22: 075-076DOI: 10.1055/s-0029-1223837© Thieme Medical PublishersGet connected:Table of contents | Full text (Source: Clinics in Colon and Rectal Surgery)
Source: Clinics in Colon and Rectal Surgery - May 28, 2009 Category: Surgery Tags: PREFACE Source Type: journals